In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tom Gallen

Managing Editor, Europe

Tom reports and edits European consumer healthcare industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switch.

Latest From Tom Gallen

People On The Move: HRA Pharma, Hofseth BioCare, UK CHM

A round-up of the latest people moves in Europe's health and wellness markets: HRA Pharma's CEO David Wright steps down; Hofseth BioCare promotes Ødegård to lead the company; and the UK's Commission on Human Medicines appoints nine new members.

Executive Changes Leadership

Bayer Places Consumer Cost Of Living Pressures 'Very High' On Agenda

Despite spiraling inflation, branded OTC product demand remains high, according to Bayer Consumer Health, which posted Q2 sales up by 16.0%. But with consumer incomes increasingly squeezed, the company is working on ways to defend its market share against cheaper private-label alternatives.

Business Strategies Sales & Earnings

Euro Results Round-Up: Karo Pharma And Recordati Post Double-Digit Gains

In the first-half of 2022, Sweden's Karo Pharma saw its sales rise by more than a third thanks to a combination of organic growth and acquisitions. Italy's Recordati reported OTC sales up by almost a fifth as the European market continued to recover post-COVID.

Sales & Earnings Europe

Less Than Four Weeks Remain To Enter The OTC Marketing Awards 2022

Entries to the OTC Marketing Awards are coming in thick and fast from industry players large and small across the 15 categories. With the entry deadline fast approaching on 29 August, don't miss out on your chance to win a prestigious trophy. 

Ad Campaigns Innovation

Nestlé Expects Continued Supplement Demand Post-Pandemic

Nestlé CEO Mark Schneider says the company's consumer research indicates that the increase in dietary supplement usage over the past couple of years will endure post-pandemic. This continued demand help to lift sales at the company's Health Science business in the first half.

Sales & Earnings Dietary Supplements

Haleon Starts Standalone Life By Raising Sales Expectations

A better than expected first-half performance has put Haleon on a sure footing for the rest of the year following its recent demerger from GSK.

Sales & Earnings OTC Drugs
See All
UsernamePublicRestriction

Register